We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+11.18%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$2.82B
AUM Growth
-$1.18B
(-30%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-46.06%
Top 10 Holdings %
Top 10 Hldgs %
18.63%
Holding
1,492
New
367
Increased
132
Reduced
283
Closed
515
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$23.4M |
| 2 |
Amgen
AMGN
|
+$7.87M |
| 3 |
Moderna
MRNA
|
+$6.95M |
| 4 |
Pinduoduo
PDD
|
+$5.73M |
| 5 |
Bank of America
BAC
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$35.8M |
| 2 |
Biogen
BIIB
|
+$9.49M |
| 3 |
Aon
AON
|
+$6.72M |
| 4 |
Sunrun
RUN
|
+$4.78M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$4.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.27% |
| 2 | Communication Services | 1.3% |
| 3 | Consumer Discretionary | 1.21% |
| 4 | Technology | 1.07% |
| 5 | Financials | 0.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEN
226
CALL
DELISTED
ZENDESK INC
ZEN
| $2.89M | 0.1% |
20,000
| – | – |
|
227
Ionis Pharmaceuticals
IONS
$8.93B
| $2.88M | 0.1% |
72,300
+52,300
| +262% | +$2.05M |
|
|
BBBY
228
CALL
Bed Bath & Beyond
BBBY
$479M
| $2.87M | 0.1% |
+34,210
| New | +$2.49M |
|
229
CALL
Nokia
NOK
$46.9B
| $2.87M | 0.1% |
539,000
-200,000
| -27% | -$965K |
|
230
Diamondback Energy
FANG
$56B
| $2.86M | 0.1% |
30,500
+15,500
| +103% | +$1.28M |
|
231
CALL
Cencora
COR
$62B
| $2.86M | 0.1% |
25,000
| – | – |
|
|
SCHW
232
PUT
Charles Schwab
SCHW
$182B
| $2.86M | 0.1% |
39,300
-75,000
| -66% | -$5.31M |
|
233
CALL
Qualcomm
QCOM
$164B
| $2.86M | 0.1% |
20,000
-19,800
| -50% | -$2.68M |
|
234
PUT
Advanced Micro Devices
AMD
$700B
| $2.82M | 0.1% |
30,000
+25,000
| +500% | +$2.02M |
|
235
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
| $2.81M | 0.1% |
33,700
-41,400
| -55% | -$3.28M |
|
236
PUT
Harley-Davidson
HOG
$2.61B
| $2.75M | 0.1% |
+60,000
| New | +$2.78M |
|
237
PUT
Teladoc Health
TDOC
$1.66B
| $2.74M | 0.1% |
16,500
| – | – |
|
238
Apple
AAPL
$4.97T
| $2.74M | 0.1% |
20,000
| – | – |
|
239
PUT
Mastercard
MA
$498B
| $2.74M | 0.1% |
+7,500
| New | +$2.79M |
|
|
PPD
240
PUT
DELISTED
PPD, Inc. Common Stock
PPD
| $2.72M | 0.1% |
+59,000
| New | +$2.67M |
|
241
CALL
Corcept Therapeutics
CORT
$9.98B
| $2.71M | 0.1% |
123,100
+93,100
| +310% | +$2.07M |
|
242
CALL
Clorox
CLX
$12B
| $2.7M | 0.1% |
15,000
| – | – |
|
|
HOLX
243
CALL
DELISTED
Hologic
HOLX
| $2.67M | 0.09% |
+40,000
| New | +$2.67M |
|
244
CALL
Gildan
GIL
$9.49B
| $2.66M | 0.09% |
+72,000
| New | +$2.52M |
|
245
PUT
Royal Caribbean
RCL
$86.8B
| $2.64M | 0.09% |
31,000
| – | – |
|
246
PUT
Bausch Health
BHC
$1.75B
| $2.64M | 0.09% |
+90,000
| New | +$2.73M |
|
|
SPWR
247
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
| $2.63M | 0.09% |
+90,000
| New | +$2.32M |
|
248
PUT
Neurocrine Biosciences
NBIX
$18.2B
| $2.63M | 0.09% |
27,000
-40,000
| -60% | -$3.83M |
|
249
CALL
Vericel Corp
VCEL
$2.38B
| $2.63M | 0.09% |
+50,000
| New | +$2.85M |
|
|
COUP
250
PUT
DELISTED
Coupa Software Incorporated
COUP
| $2.62M | 0.09% |
+10,000
| New | +$2.48M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q2 2021 Portfolio in Review
As of Q2 2021, SG3 Management held 1,492 positions worth $2.82B, down 30% from $4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
SG3 Management withdrew a net $1.3B in Q2 2021, closing 515 positions and reducing 283 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $35.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 2.3% of assets, up from 1.8% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, SG3 Management opened a new position in Alphabet (Google) Class A worth $24.4M.
- SG3 Management's largest Q2 2021 buy was Alphabet (Google) Class A: 200,000 shares worth $24.4M.
- SG3 Management added most to Pinduoduo in Q2 2021, an estimated $5.73M increase.
- SG3 Management's biggest Q2 2021 reduction was Paramount Global Class B, cutting an estimated $4.32M.
- SG3 Management fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $35.8M.
- SG3 Management's ten largest holdings make up 19% of its $2.82B portfolio in Q2 2021.
- SG3 Management opened 367 new positions and closed 515 in Q2 2021.
- SG3 Management's portfolio value fell 30% quarter-over-quarter to $2.82B.
Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.